These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 25606058)

  • 1. Systematic evaluation of connectivity map for disease indications.
    Cheng J; Yang L; Kumar V; Agarwal P
    Genome Med; 2014; 6(12):540. PubMed ID: 25606058
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DMAP: a connectivity map database to enable identification of novel drug repositioning candidates.
    Huang H; Nguyen T; Ibrahim S; Shantharam S; Yue Z; Chen JY
    BMC Bioinformatics; 2015; 16 Suppl 13(Suppl 13):S4. PubMed ID: 26423722
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of analytical methods for connectivity map data.
    Cheng J; Xie Q; Kumar V; Hurle M; Freudenberg JM; Yang L; Agarwal P
    Pac Symp Biocomput; 2013; ():5-16. PubMed ID: 23424107
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comprehensive evaluation of connectivity methods for L1000 data.
    Lin K; Li L; Dai Y; Wang H; Teng S; Bao X; Lu ZJ; Wang D
    Brief Bioinform; 2020 Dec; 21(6):2194-2205. PubMed ID: 31774912
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of connectivity map shows limited reproducibility in drug repositioning.
    Lim N; Pavlidis P
    Sci Rep; 2021 Sep; 11(1):17624. PubMed ID: 34475469
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gene-Set Local Hierarchical Clustering (GSLHC)--A Gene Set-Based Approach for Characterizing Bioactive Compounds in Terms of Biological Functional Groups.
    Chung FH; Jin ZH; Hsu TT; Hsu CL; Liu HC; Lee HC
    PLoS One; 2015; 10(10):e0139889. PubMed ID: 26473729
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Querying genomic databases: refining the connectivity map.
    Segal MR; Xiong H; Bengtsson H; Bourgon R; Gentleman R
    Stat Appl Genet Mol Biol; 2012 Jan; 11(2):. PubMed ID: 22499690
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Revisiting Connectivity Map from a gene co-expression network analysis.
    Liu W; Tu W; Li L; Liu Y; Wang S; Li L; Tao H; He H
    Exp Ther Med; 2018 Aug; 16(2):493-500. PubMed ID: 30112021
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reconciling multiple connectivity scores for drug repurposing.
    Samart K; Tuyishime P; Krishnan A; Ravi J
    Brief Bioinform; 2021 Nov; 22(6):. PubMed ID: 34013329
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Systematic drug safety evaluation based on public genomic expression (Connectivity Map) data: myocardial and infectious adverse reactions as application cases.
    Wang K; Weng Z; Sun L; Sun J; Zhou SF; He L
    Biochem Biophys Res Commun; 2015 Feb; 457(3):249-55. PubMed ID: 25576362
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Decoding Connectivity Map-based drug repurposing for oncotherapy.
    Zhao Y; Chen X; Chen J; Qi X
    Brief Bioinform; 2023 May; 24(3):. PubMed ID: 37068308
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Systematic polypharmacology and drug repurposing via an integrated L1000-based Connectivity Map database mining.
    Liu TP; Hsieh YY; Chou CJ; Yang PM
    R Soc Open Sci; 2018 Nov; 5(11):181321. PubMed ID: 30564416
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Estimating intraclonal heterogeneity and subpopulation changes from bulk expression profiles in CMap.
    Hsieh CY; Tu CC; Hung JH
    Life Sci Alliance; 2022 Oct; 5(10):. PubMed ID: 35688486
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drug-repurposing identified the combination of Trolox C and Cytisine for the treatment of type 2 diabetes.
    Jin L; Tu J; Jia J; An W; Tan H; Cui Q; Li Z
    J Transl Med; 2014 May; 12():153. PubMed ID: 24885253
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gene-disease association with literature based enrichment.
    Tsafnat G; Jasch D; Misra A; Choong MK; Lin FP; Coiera E
    J Biomed Inform; 2014 Jun; 49():221-6. PubMed ID: 24681202
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DIGEP-Pred 2.0: A web application for predicting drug-induced cell signaling and gene expression changes.
    Ivanov SM; Rudik AV; Lagunin AA; Filimonov DA; Poroikov VV
    Mol Inform; 2024 Dec; 43(12):e202400032. PubMed ID: 38979651
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Discovery of the neuroprotective effects of alvespimycin by computational prioritization of potential anti-Parkinson agents.
    Gao L; Zhao G; Fang JS; Yuan TY; Liu AL; Du GH
    FEBS J; 2014 Feb; 281(4):1110-22. PubMed ID: 24304935
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fish connectivity mapping: linking chemical stressors by their mechanisms of action-driven transcriptomic profiles.
    Wang RL; Biales AD; Garcia-Reyero N; Perkins EJ; Villeneuve DL; Ankley GT; Bencic DC
    BMC Genomics; 2016 Jan; 17():84. PubMed ID: 26822894
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In-silico drug screening and potential target identification for hepatocellular carcinoma using Support Vector Machines based on drug screening result.
    Yang WL; Lee YE; Chen MH; Chao KM; Huang CY
    Gene; 2013 Apr; 518(1):201-8. PubMed ID: 23220021
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NMR spectroscopy-based metabolic profiling of drug-induced changes in vitro can discriminate between pharmacological classes.
    Aftab O; Engskog MK; Haglöf J; Elmsjö A; Arvidsson T; Pettersson C; Hammerling U; Gustafsson MG
    J Chem Inf Model; 2014 Nov; 54(11):3251-8. PubMed ID: 25321343
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.